The diversity issue, it struck me, involves far more than just clinical trials. Judging from the list of attendees at the meeting, women are becoming well represented in the field of biological research. But there were very few African Americans, either at the conference or on the benches in the various labs I had visited. In that regard, the new life-sciences revolution resembles, unfortunately, the digital revolution. If there are not efforts at outreach and mentorship, biotechnology will be yet another revolution that leaves most Blacks behind.
